---
figid: PMC9512673__gr7
pmcid: PMC9512673
image_filename: gr7.jpg
figure_link: /pmc/articles/PMC9512673/figure/fig7/
number: FigureÂ 7
figure_title: ''
caption: Schematic diagram of MEK-inhibitor-resistance mechanism in TNBC cells(A and
  B) Activation of the AKT pathway by MEK inhibition contributes to drug resistance
  in MEKi-sensitive TNBC cells.(C and D) The proteasome-autophagy balance mediates
  drug resistance in MEKi-resistant TNBC cells.
article_title: PSMG2-controlled proteasome-autophagy balance mediates the tolerance
  for MEK-targeted therapy in triple-negative breast cancer.
citation: Xueyan Wang, et al. Cell Rep Med. 2022 Sep 20;3(9):100741.
year: '2022'

doi: 10.1016/j.xcrm.2022.100741
journal_title: Cell Reports Medicine
journal_nlm_ta: Cell Rep Med
publisher_name: Elsevier

keywords:
- PDPK1
- PSMG2
- autophagy
- proteasome
- MAPK pathway
- AKT pathway
- CRISPR-Cas9
- triple-negative breast cancer
- targeted therapy
- resistance

---
